The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2017

Filed:

Mar. 28, 2013
Applicant:

Kyoto University, Kyoto-shi, Kyoto, JP;

Inventors:

Kenji Nakayama, Kyoto, JP;

Kazuharu Shimizu, Kyoto, JP;

Jun Utsumi, Kyoto, JP;

Takahiro Inoue, Kyoto, JP;

Osamu Ogawa, Kyoto, JP;

Assignee:

KYOTO UNIVERSITY, Kyoto-Shi, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/493 (2006.01); G01N 33/574 (2006.01); G01N 33/68 (2006.01); C12N 9/64 (2006.01);
U.S. Cl.
CPC ...
G01N 33/493 (2013.01); C12N 9/6424 (2013.01); G01N 33/57434 (2013.01); G01N 33/6851 (2013.01); C12Y 304/21077 (2013.01);
Abstract

A novel method that enables prostate cancer testing that is noninvasive and more accurate than conventional methods is disclosed. The present inventors intensively analyzed urine samples from prostate cancer patients, and non-cancer subjects, who are free of prostate cancer, and, as a result, newly discovered urinary peptides that can be used as indicators in prostate cancer testing. Use of these urinary peptides as indicators enables various prostate cancer-related tests including detection of prostate cancer, discrimination between prostate cancer and benign prostatic hyperplasia, monitoring of a therapeutic effect of prostate cancer therapy and monitoring of postoperative recurrence.


Find Patent Forward Citations

Loading…